MktsMarkets

Novavax, Inc.
NASDAQ: NVAXKey statistics
NVAX News
Stories mentioning NVAX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 139,514 | 147,139 | 70,445 | 239,240 | 666,655 | 88,311 | 84,512 | 415,484 |
| Cost of Goods Sold | 30,695 | 22,104 | 21,496 | 15,325 | 14,115 | 36,669 | 60,619 | 46,242 |
| Gross Profit | 108,819 | 125,035 | 48,949 | 223,915 | 652,540 | 51,642 | 23,893 | 369,242 |
| Operating Expenses | ||||||||
| Research & Development | 95,472 | 75,876 | 98,274 | 79,233 | 88,937 | 104,380 | 87,164 | 106,946 |
| Sales General & Admin | 28,777 | 31,655 | 48,090 | 70,747 | ||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (15,430) | 14,230 | (178,018) | 101,070 | 515,513 | (131,080) | (134,018) | 160,998 |
| Interest Income | 7,100 | 7,300 | 7,200 | 7,000 | 8,000 | 12,300 | 9,000 | |
| Interest Expense | ||||||||
| Other Expense | 11,825 | 9,497 | 9,178 | 11,902 | 10,056 | 13,135 | 15,922 | 7,731 |
| Pretax Income | (8,506) | 17,903 | (203,036) | 107,454 | 519,846 | (73,581) | (122,332) | 164,586 |
| Tax Provision | 985.00 | 376.00 | (657.00) | 946.00 | 1,200 | 7,449 | (1,032) | 2,205 |
| Net Income (Loss) | (9,491) | 17,527 | (202,379) | 106,508 | 518,646 | (81,030) | (121,300) | 162,381 |
| Earnings Per Share (Basic) | (0.06) | 0.11 | (1.25) | 0.66 | 3.22 | (0.53) | (0.76) | 1.09 |
| Earnings Per Share (Diluted) | (0.06) | 0.10 | (1.25) | 0.62 | 2.93 | (0.53) | (0.76) | 0.99 |
| Weighted Average Shares Outstanding (Basic) | 163,276 | 161,991 | 162,353 | 162,019 | 161,049 | 152,190 | 160,049 | 148,379 |
| Weighted Average Shares Outstanding (Diluted) | 163,276 | 173,103 | 162,353 | 177,215 | 177,625 | 152,190 | 160,049 | 165,855 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NVAX
Novavax, Inc. (NASDAQ: NVAX) is a stock listed on the Nasdaq Stock Market under the ticker symbol NVAX. It last traded at $10.20 (Nov 10, 2026, 4:00 PM ET), down 6.3% on the day. That gives Novavax a market capitalisation of $1.8B.
Over the past 52 weeks NVAX has traded between $6.20 and $13.38.
Revenue for the quarter ended Mar 31, 2026 was $139.5M; a net loss of $9.5M. Revenue was down 79.1% from $666.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $139.5M | -$9.5M | -6.8% |
| Dec 31, 2025 | $147.1M | $17.5M | 11.9% |
| Sep 30, 2025 | $70.4M | -$202.4M | -287.3% |
| Jun 30, 2025 | $239.2M | $106.5M | 44.5% |
From Novavax’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…